Next, the authors tested the ability of CAR-T M27-28BBZ cells to inhibit the growth of glioma cells expressing EGFRvIII, EGFR or both antigens in orthotopic GBM xenografts models. The gene discussed is EGFR; the disease is central nervous system cancer.